Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19) (LUS-COVID19)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04393402|
Recruitment Status : Recruiting
First Posted : May 19, 2020
Last Update Posted : May 19, 2020
It might be necessary with Sars-Cov2 pneumopathy patient to repeat thoracic images, the tomodensitometry ones in particular. This task is difficult and nearly impossible for several reasons: respiratory and hemodynamic unstable patient, prone position and due to the high contagious nature of the disease.
The lung ultrasound is an easy tool, fast (between 5 and 10 minutes) and as a limited training.
In the context of the Sars-Cov2 epidemic, Buonsenso and al case report depict the first lung ultrasound for a Covid 19 patient.
Peng and al in Intensive Care Medicine accentuate the usefulness of this particular technic.
In the American Journal of Respiratory and Critical Care Medicine, a study has been published as a point-of-care, in which the doctors reported using the lung ultrasound with intensive and critical care patient.
In Critical Care 2016, it has been showed that ultrasound allowed with neat precisions, to predict severe ARDS patient response to the prone position, all-cause.
Another researchers team found a good correlation between lung ultrasound, the SOFA, APACHE II, CPIS score, and patient mortality.
And a new applicability in the pulmonary recruitment by PEEP titration has been presented.
The aim of this study is to evaluate the lung ultrasound in Covid19 ARDS.
|Condition or disease||Intervention/treatment|
|COVID||Procedure: lung ultrasound (LUS)|
|Study Type :||Observational|
|Estimated Enrollment :||14 participants|
|Official Title:||Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care|
|Actual Study Start Date :||March 20, 2020|
|Estimated Primary Completion Date :||December 31, 2020|
|Estimated Study Completion Date :||December 31, 2020|
|Patients with Covid-19 and admitted in critical care unit||
Procedure: lung ultrasound (LUS)
Patients with Covid-19 Disease and admitted in critical care unit will be performed a LUS
- LUS applicability with COVID 19 [ Time Frame: 10 months ]In dorsal position, or in prone position, the two hemithorax will be subdivided in 6 parts, and a score will be attributed with the following criteria : A-Lines (0 point), > 3 B-lines (1 point), B-Lines coalscent (2 points), and pulmonary consolidation (3 points). For the echography we can use a convexe sonde, or a "cardiac" sonde.
- Radiographic correlation (chest Xray and tomodensitometry) [ Time Frame: 10 months ]Comparison between Xray / CT scan exam and LUS
- LUS Mortality prediction [ Time Frame: 10 months ]according to LUS score, ventilatory mode and parameters, medical history and bood analysis results
- Prediction of Prone position response [ Time Frame: 10 months ]comparison of LUS score depending of the position used for performing LUS
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04393402
|Contact: Jean DELLAMONICA, MD, PhD||+334 92 03 55 email@example.com|
|Contact: Romain LOMBARDI||+336 69 03 26 firstname.lastname@example.org|